Latest news posts

All news posts

nicotine tartrate dihydrate

Enorama Pharma submitted requested additions on its MAA to the Swedish MPA

Additions sent in four weeks before schedule.

cannabis lab

Enorama Pharma establishes a laboratory for medical cannabis

The lab will continue the very promising project and implement prototype development of a medical cannabis chewing gum.

cough & cold

Enorama Pharma enters into agreements regarding screening study within Cough & Cold

The cost of this initial analysis is covered by MediiGum LLC.

CEO mats ronngard

Enorama Pharmas preferential rights issue oversubscribed

A few days after the announcement, we would like to reflect on the strong outcome and the great interest.

cannabis flos

Enorama Pharma receives permission to handle cannabis

The permit allows the company to begin the work of developing a medical cannabis chewing gum.

nicotine chewing gum

Enorama receives wholesale license from the Swedish MPA

Enorama Pharma now has all the approvals required to apply for registration of medical products in Europe.

Wholesale license application at the Swedish MPA

Enorama Pharma AB announces that the Company has applied for a wholesale license at the Swedish Medical Products Agency (MPA) and the inspection date is set to July 24th.

BioStock: Today we celebrate "World No Tobacco Day"

World Health Organization WHO estimates that there are about 1 billion smokers in the world.